Microaxial flow pump improves infarct-related cardiogenic shock outcomes
1. In this randomized controlled trial, in patients with infarct-relate cardiogenic shock, death from any cause was lower in the group that received the microaxial flow pump compared to the group that received the standard care. 2. The composite safety endpoint occurred in more patients in the microaxial flow pump group than in the standard
Minute Medicine Inc Rating Level Confidence Interval Cardiogenic Shock Infarct Related Cardiogenic Shock Microaxial Flow Pump
Source: 2minutemedicine.com